Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016

Whole-Genome Sequencing to Identify Missed Rifampicin and Isoniazid Resistance Among Tuberculosis Isolates—Chennai, India, 2013–2016

India has a high burden of drug-resistant tuberculosis (DR TB) and many cases go undetected by current drug susceptibility tests (DSTs). This study was conducted to identify rifampicin (RIF) and isoniazid (INH) resistance associated genetic mutations undetected by current clinical diagnostics amongs...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sembulingam Tamilzhalagan, Sivakumar Shanmugam, Ashok Selvaraj, Sakthi Suba, Chittibabu Suganthi, Patrick K. Moonan, Diya Surie, Mukesh Kumar Sathyanarayanan, Narayanan Shivaram Gomathi, Lavanya Jayabal, Kuldeep Singh Sachdeva, Sriram Selvaraju, Soumya Swaminathan, Srikanth Prasad Tripathy, Patricia J. Hall, Uma Devi Ranganathan
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
drug susceptibility testing
genetic mutations
line probe assay
whole genome sequencing
DR TB
Microbiology
QR1-502
Accès en ligne:https://doaj.org/article/ff71cca09e6948818bf864696a9fed21
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/ff71cca09e6948818bf864696a9fed21

Documents similaires